细小病毒B19激活正常人真皮成纤维细胞:与皮肤纤维化及系统性硬化症的可能关联
本研究探讨细小病毒B19(B19V)能否在体外激活正常人真皮成纤维细胞(NHDFs)并诱导类似系统性硬化症(SSc)成纤维细胞的表型。结果显示B19V感染NHDFs后虽不产生完整病毒,但显著增强细胞迁移与侵袭能力,并上调多种促纤维化、炎症小体相关及基质金属蛋白酶基因的mRNA表达。提示B19V可能通过激活真皮成纤维细胞参与纤维化发病过程。
要点
- B19V可感染NHDFs但不产生完整病毒,感染后细胞迁移和侵袭能力显著增强。
- B19V上调促纤维化基因(α-SMA、EDN-1、IL-6、TGF-β受体1/2、Col1α2)mRNA表达。
- B19V诱导炎症小体相关基因和MMP2/9/12表达,MMP9过表达可能介导侵袭表型。
核心结论
- B19V可在体外激活正常人真皮成纤维细胞,诱导促纤维化、炎症小体相关及基质金属蛋白酶基因表达,提示其可能参与纤维化发病过程。
研究设计与样本
- 体外实验研究:先分析B19V感染培养NHDFs的时间进程,再检测B19V诱导细胞迁移、侵袭表型及促纤维化/促炎基因mRNA表达的能力。
主要发现
- B19V感染NHDFs但不产生完整病毒。
- 孵育B19V后NHDFs迁移和侵袭能力显著增加。
- 促纤维化基因(α-SMA、EDN-1、IL-6、TGF-β1受体1和2、Col1α2)mRNA表达升高。
- 炎症小体平台相关基因(AIM2、IFI16、IL-1β、CASP-1)及金属蛋白酶基因(MMP2、MMP9、MMP12)mRNA表达升高。
临床怎么用
- 提示B19V感染可能通过激活真皮成纤维细胞参与SSc皮肤纤维化,为发病机制研究提供线索。
局限性
- 研究为体外细胞实验,结论需进一步体内研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Fibrosis is the most characteristic pathological hallmark of SSc, a connective tissue disease characterized by vascular and immunological abnormalities, inflammation and enhanced extracellular matrix production, leading to progressive fibrosis of skin and internal organs. We previously demonstrated that parvovirus B19 (B19V) can infect normal human dermal fibroblasts (NHDFs) and that B19V persists in SSc fibroblasts. In this study, we investigated whether parvovirus B19V is able to activate in vitro NHDFs and to induce in these cells some phenotypic features similar to that observed in the SSc fibroblasts. METHODS: We preliminarily analysed the time course of B19V infection in cultured NHDFs, then we investigated the ability of B19V to induce cell migration, invasive phenotype and mRNA expression of some profibrotic and/or proinflammatory genes. RESULTS: We confirmed our previous findings that B19V infects NHDFs, but the infection is not productive. After incubation with B19V, NHDFs showed a significant increase of both migration and invasiveness, along with mRNA expression of different profibrotic genes (α-SMA, EDN-1, IL-6, TGF-β1 receptors 1 and 2, Col1α2), some genes associated with inflammasome platform (AIM2, IFI16, IL-1β, CASP-1) and genes for metalloprotease (MMP 2, 9 and 12). CONCLUSION: These data suggest that B19V can activate dermal fibroblasts and may have a role in the pathogenesis of fibrosis. B19V-induced fibroblast migration and invasiveness could be due to the B19V-associated MMP9 overexpression and activation. Moreover, the up-regulation of MMP12, typical of SSc, could link the B19V infection of fibroblasts to the anti-angiogenic process.
引用
- Arvia R, Margheri F, Stincarelli MA, et al. Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis. Rheumatology (Oxford). 2020. PMID: 32556240. doi:10.1093/rheumatology/keaa230
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。